Therapy of Percentual Hearing Loss by Rheohemapheresis – First Experience
Authors:
J. Dršata 1; M. Bláha 2; Viktor Chrobok 1; E. Rencová 3; M. Lánská 2
Authors‘ workplace:
Klinika otorinolaryngologie a chirurgie hlavy a krku, Fakultní nemocnice Hradec Králové, Univerzita Karlova v Praze, Lékařská fakulta v Hradci Králové
1; IV. interní hematologická klinika, Fakultní nemocnice Hradec Králové, Univerzita Karlova v Praze, Lékařská fakulta v Hradci Králové
2; Oční klinika, Fakultní nemocnice Hradec Králové, Univerzita Karlova v Praze, Lékařská fakulta v Hradci Králové
3
Published in:
Otorinolaryngol Foniatr, 63, 2014, No. 3, pp. 163-169.
Category:
Original Article
Overview
Sudden hearing loss (sudden idiopathic sensorineural hearing loss, SISHL) is a major medical, social and economic problem. The etiology is not fully understood; the problem is arising presumably by the action of heterogeneous factors (viral infections, immunologic or vascular disorders etc.). Treatment of SISHL is generally not satisfactory, both in terms of corticosteroids or other options. Rheohemapheresis (RHF) offers a possibility of a rescue treatment. It is based on a rapid improvement of rheologic properties of blood that can favorably affect the viscosity and thus the flow of the microcirculation, coagulation or activity of the endothelium. In the years 2012 – 2013, we treated 16 patients in the age 34 – 72 years by means of our own modification of RHF, after treatment failure with corticoid infusion therapy. Hearing improvement was achieved significantly in 11 patients according to WHO rating, respectively in 12 diseased according to Fowler counting. 5 patients did not improve significantly, at one patient the hearing worsened. Most patients achieved an improvement at a frequency of 0.5 kHz. Tinnitus disappeared in two patients, and average tinnitus reduction was achieved 15.25 dB. Unfavorable prognostic factor showed to be the severity of hearing loss and age of the patient and the time of the incident. RHF side effects were not significant (two short-term non-serious reactions). RHF in our study showed a beneficial therapeutic effect even after a failed conventional therapy and subsequent initiation of treatment and was not associated with significant adverse risks. Treatment results of our group support the hypothesis that RHF may be an alternative rescue therapy in SISHL, especially in case of a vascular etiology, even after a failure of a standard therapy.
Keywords:
sudden sensorineural hearing loss (SISHL), heterogeneous factors, rheohemapheresis
Sources
1. Aimoni, C., Bianchini, C., Borin, M. et al.: Diabetes, cardiovascular risk factors and idiopathic sudden sensorineural hearing loss: a case-control study, Audio. Neurootol., 15, 2010, 2, s. 111-115.
2. Anniko, M.: Otorhinolaryngology, Head and Neck Surgery (European Manual of Medicine). Springer, 2010, s. 114-115.
3. Bláha, M., Cermanová, M., Bláha, V. et al.: Safety and tolerability of long lasting LDL-apheresis in familial hyperlipoproteinemia. Ther Apher Dial, 11, 2007, 1, s. 9-15.
4. Bláha, M., Rencova, E., Bláha, V. et al.: Rheopheresis in vascular diseases. Int. J. Artif Organs, 31, 2008, 5, s. 456-457.
5. Bláha, M., Rencová, E., Bláha, V. et al.: The importance of rheological parameters in the therapy of microcirculatory disorders, Clin. Hemorheol. Microcirc., 42, 2009, 1, s. 37-46.
6. Bláha, M., Rencová, E., Langrová, H., Lánská, M., Bláha, V., Studnička, J., Rozsíval, P., Malý, R., Fátorová, I., Filip, S., Dršata, J., Hejsek, L., Malý, J.: The importance of rheological parameters in the therapy of the dry form of age-related macular degeneration with rheohaemapheresis. Clin. Hemorheol. Microcirc., 50, 2012, 4, s. 245-255.
7. Bláha, M.: Rheologické poruchy v onkologii. Část III.: Terapeutická plazmaferéza a její uplatnění v onkologii, Lék. Zpr. LF UK Hradec Králové, 47, 2002, 5-6, s. 161-167.
8. Conlin, E. A., Parnes, L. S.: Treatment of sudden sensorineural hearing loss: II. A Meta-analysis. Arch. Otolaryngol. Head Neck Surg., 133, 2007, 6, s. 582-586.
9. Dršata, J., Bláha, M., Chrobok, V. et al.: Treatment of sudden sensorineural hearing loss with rheohaemapheresis. Sborník abstrakt XVII. vědecké konference LF UK v Hradci Králové a FN Hradec Králové, 23. 1. 2013, Hradec Králové, LF HK, 2013, s. 27.
10. Eisenman, D., Arts, H. A.: Effectiveness of treatment for sudden sensorineural hearing loss, Arch. Otolaryngol. Head Neck Surg., 126, 2000, 9, s. 1161-1164.
11. Finger, R. P., Gostian, A. O.: Apheresis for idiopathic sudden hearing loss: Reviewing the evidence. J. Clin. Apheresis, 21, 2006, 4, s. 241-245.
12. Foden, N., Mehta, N., Joseph, T.: Sudden onset hearing loss – causes, investigations and management. Aust. Fam. Physician, 42, 2013, 9, s. 641-644.
13. Fukui, M., Kitagawa, Y., Nakamura, N. et al.: Idiopathic sudden hearing loss in patients with type 2 diabetes, Diabetes Research and Clinical Practice, 63, 2004, 3, s. 205-211.
14. Harris, J., Sharp, P.: Inner ear antibodies in patients with rapidly progressive sensorineural hearing loss. Laryngoscope, 1990, 100, s. 516-524.
15. Heigl, F., Hettich, R., Suckfuell, M. et al.: Fibrinogen/LDL apheresis as successful second-line treatment of sudden hearing loss: a retrospective study on 217 patients. Atheroscler Suppl, 10, 2009, 5, s. 95-101.
16. Chae, S. W., Cho, J. H., Lee, J. H. et al.: Sudden hearing loss in chronic myelogenous leukaemia implicating the hyperviscosity syndrome, J. Laryngol. Otol., 116, 2002, 4, s. 291-293.
17. Jones, N. S., Davis, A.: A prospective case-controlled study of patients presenting with idiopathic sensorineural hearing loss to examine the relationship between hyperlipidaemia and sensorineural hearing loss 1. Clinical Otolaryngology & Allied Sciences, 1999, 24, 6, s. 531-536.
18. Klemm, E., Deutscher, A., Mösges, R.: A present investigation of the epidemiology in idiopathic sudden sensorineural hearing loss. Laryngo-Rhino-Otologie, 88, 2009, s. 524-527.
19. Klingel, R., Heibges, A., Uygun-Kiehne, S., Fassbender, C., Mösges, R.: Rheopheresis for sudden sensorineural hearing loss. Atheroscler. Suppl., 10,2009, 5, s. 102-106.
20. Labus, J., Breil, J., Stutzer, H. et al.: Meta-analysis for the effect of medical therapy vs. placebo on recovery of idiopathic sudden hearing loss. Laryngoscope, 120, 2010, 9, s. 1863-1871.
21. Lánská, M., Bláha, M., Fátorová, I., Košťál, M., Mašín, V.: The activity of selected platelet and coagulation markers after LDL-pheresis and rheopheresis. Sborník abstrakt z XVI. vědecká konference LF UK, Hradec Králové, 25. 1. 2012, s. 45.
22. Lin, R. J., Krall, R., Westerberg, B. D., Chadha, N. K.,Chau, J. K.: Systematic review and meta-analysis of the risk factors for sudden sensorineural hearing loss in adults. Laryngoskope, 122, 2012, 3, s. 624-635.
23. Marthedal, E., Geib, A. J., McCoy, J.: An unusual case of sudden hearing loss in a young man. JAAPA, 26, 2013, 8, s. 38-41.
24. Michel, O., Jahns, T., Joost-Enneking, M. et al.: Das antiphlogistisch-rheologische Infusionsschema nach Stennert in der Behandlung von kochleovestibulären Störungen. HNO, 48, 2000, 3, s. 182-188.
25. Miller, J., Dengerink, H.: Control of inner ear blood flow. Am. J. Otolaryngol., 1998, 9, s. 302-316.
26. Mösges R., Köberlein J., Heibges A., Erdtracht B., Klin-gel R., Lehmacher W.: Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial. Eur. Arch. Otorhinolaryngol., 266, 2009, 7, 943-953.
27. Mosnier, I., Stepanian, A., Baron, G. et al.: Cardiovascular and thromboembolic risk factors in idiopathic sudden sensorineural hearing loss: A case-control study. Audio. Neurotik., 16, 2011, 1, s. 55-66.
28. Nakamura, M., Whitlock, G., Aoki, N. et al.: Japanese and Western diet and risk of idiopathic sudden deafness: a case-control study using pooled controls. Internat. J. Epidemiol, 30, 2001, 3, s. 608-615.
29. Nakashima, T., Yanagita, Y., Ohno, J., Kanzaki, T., Shi-tara, T.: Comparative study on sudden deafness by two nationwide epidemiological surveys in Japan.. Acta Otolaryngol. Stockh., 514, 1994, s. 14-16.
30. Ness, J. A., Stankiewicz, J. A., Kaniff, T. et al.: Sensorineural hearing loss associated with aortocoronary bypass surgery: A prospective analysis. Laryngoscope, 103, 1993, 6, s. 589-593.
31. Oreskovic, Z., Shejbal, D., Bicanic, G. et al.: Influence of lipoproteins and fibrinogen on pathogenesis of sudden sensorineural hearing loss. J. Laryngol. Otol., 125, 2011, 3, s. 258-261.
32. Pitkäranta, A., Vasama, J. P., Julkunen, I.: Sudden deafness and viral infections. Oto-Rhino-Laryngologia Nova, 9, 1999, 5, s. 190-197.
33. Plasse, H. M., Mittleman, M., Frost, J. O.: Unilateral sudden hearing loss after open heart surgery: A detailed study of seven CASE. Laryngoscope, 91, 1981, 1, s. 101-109.
34. Seidel, D.: LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy. Z. Kardiol., 92, 2003; (Suppl 3), III, s. 6-27.
35. Schillaci, G., Pirro, M., Vaudo, G. et al.: Prognostic value of the metabolic syndrome in essential hypertension. Journal of the American College of Cardiology, 43, 2004, 10, s. 1817-1822.
36. Schwartz, J., Winters, J. L., Padmanabhan, A., Balo-gun, R. A., Delaney, M., Linenberger, M. L., Szczepiorkow-ski, Z. M., Williams, M. E., Wu, Y., Shaz, B. H.: Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J. Clin. Apher., 28, 2013, 3, s. 145-284.
37. Snow, J. B., Wackym, P. A., Ballenger, J. J.: Otorhino-laryngology. People‘s Medical Publishing House/B C Decker, 2009, s. 279-282.
38. Stachler, R. J., Chandrasekhar, S. S., Archer, S. M. et al.: Clinical practice guideline: sudden hearing loss. Otolaryngology-head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery, 146, 2012, 3 Suppl, s. S1-35.
39. Suckfüll, M., Thiery, J., Schorn, K. et al.: Clinical utility of LDL-apheresis in the treatment of sudden hearing loss: a prospective, randomized study. Acta Oto-Laryngologica, 119, 1999, 7, s. 763-766.
40. Suckfüll, M., Wimmer, C., Reichel, O. et al.: Hyper-fibrinogenemia as a risk factor for sudden earing loss. Otology & Neurotology, 23, 2002, 3, s. 309-311.
41. Suckfüll, M.: Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial, Lancet, 360, 2002, s. 1811-1817.
42. Suckfüll, M.: Perspectives on the pathophysiology and treatment of sudden idiopathic sensorineural hearing loss. Dtsch. Arztebl. Int., 106, 2009, 41, s. 669-675; quiz 676.
43. Ullrich, H., Kleinjung, T., Steffens, T. et al.: Improved treatment of sudden hearing loss by specific fibrinogen aphaeresis. J. Clinical Apheresis, 19, 2004, 2, s. 71-78.
44. Wei, X., He, J.: Analysis of prognostic factors for sudden sensorineural hearing loss. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 25, 2011, 13, s. 599-601.
45.Wu, C. S., Yang, T. H., Lin, H. C., Sheu, J. J., Chu, D.: Sudden sensorineural hearing loss associated with chronic periodontitis: a population-based study. Otol. Neurotol., 34, 2013, 8, s. 1380-1384.
Labels
Audiology Paediatric ENT ENT (Otorhinolaryngology)Article was published in
Otorhinolaryngology and Phoniatrics
2014 Issue 3
Most read in this issue
- Therapy of Percentual Hearing Loss by Rheohemapheresis – First Experience
- Facial (Craniofacial) Epitheses
- Effects of Lactoflora Administered Nasally: Results of a Primary Study
- Importance of Vascular Endothelial Growth Factor (VEGF) for Metastatic Dissemination of Adenoid Cystic Carcinoma of Salivary Glands